gut.bmj2d
Reparative immunological consequences of stem cell transplantation as a cellular therapy for refractory Crohn’s disease
Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...
gut.bmj1d
Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort study
Correspondence to Dr Ka Shing Cheung, Department of Medicine, The University of Hong Kong, Hong Kong 999077, Hong Kong; cks634{at}hku.hk; Prof Wai-Kay Seto; wkseto{at}hku.hk Objective Whether varying ...
gut.bmj1d
Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment
Objective Pancreatic ductal adenocarcinoma (PDAC) shows a remarkable predilection for liver metastasis. Pro-oncogenic secretome delivery and trafficking via exosomes are crucial for pre-metastatic ...
gut.bmj1d
PTU-211 Patient preparation prior to gastroscopy: a UK wide survey
Introduction Background: Optimal patient preparation for colonoscopy is shown to improve polyp detection in the colon. In Japan, it is widely accepted practice to administer a mucolytic agent prior to ...
gut.bmj13d
Early Crohn disease: a proposed definition for use in disease-modification trials
Crohn disease is a chronic condition characterised by intestinal inflammation and progressive bowel damage associated with impaired functioning. In rheumatoid arthritis, which shares some common ...
gut.bmj2d
Wheat bran affects the site of fermentation of resistant starch and luminal indexes related to colon cancer risk: a study in pigs
Dr M J A P Govers, Numico Research BV, PO Box 7005, 6700 CA Wageningen, The Netherlands. BACKGROUND Recent studies suggest that resistant starch (effective in producing butyrate and lowering possibly ...
gut.bmj3d
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
4 Department of Hepatogastroenterology, Hopital Claude Huriez, CHRU Lille, France Correspondence to: Professor J-F Colombel Department of Hepato-Gastroenterology, Hopital Claude Huriez, CHRU de Lille, ...
gut.bmj11d
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
Correspondence to Professor Giovanni Targher, Endocrinology and Metabolism, University of Verona Department of Medicine, Verona 37126, Italy; giovanni.targher{at}univr.it Non-alcoholic fatty liver ...
gut.bmj6d
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis
Introduction Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease, with type 2 diabetes mellitus (T2DM) as a major predictor. Insulin resistance and chronic ...
gut.bmj6d
Gastrointestinal epithelial neoplasia: Vienna revisited
International consensus meetings in Padova and Vienna have attempted to rationalise the grading and classification of gastrointestinal epithelial neoplasia (GEN). With its minor adjustments, the ...
gut.bmj12d
The future of drug development for inflammatory bowel disease: the need to ACT (advanced combination treatment)
Correspondence to Dr Silvio Danese, Gastroenterology and Gastrointestinal Endoscopy Unit, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milano, Lombardia, Italy; ...
gut.bmj7d
Alcohol inhibits T-cell glucose metabolism and hepatitis in ALDH2-deficient mice and humans: roles of acetaldehyde and glucocorticoids
Correspondence to Prof Junqi Niu, Department of Hepatology, First Affiliated Hospital, Jilin University, Changchun, China; junqiniu{at}aliyun.com and Dr Bin Gao, Laboratory of Liver Diseases, National ...